Regenerative Medicine Co. Raises Series C

Aldagen Inc., a Durham, N.C.-based regenerative medicine company focused on vascular and degenerative diseases, has raised $14.3 million in Series C funding. Harbert Venture Partners and Intersouth Partners co-led the deal, and were joined by return backers Aurora Funds, Trelys Funds, Tall Oaks Capital, Village Ventures and the Piedmont Angel Network. The company also raised $3 million in debt financing from Square 1 Bank. The Company will use these funds to advance its pipeline of regenerative medicine clinical studies.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />